Established in 1978, Chain Drug Review has come to be recognized by industry professionals as the most influential and authoritative news publication serving the $145 billion chain drug store industry.
The reach and readership presently delivered by Chain Drug Review is second to none. Chain Drug Review delivers a powerful audience of subscribers that is comprised of chain drug headquarter executives, merchandise managers, buyers, administrative and operations management, district/regional managers, pharmacists, pharmacy managers and store-level managers. As the premier publication serving the chain drug industry, Chain Drug Review has become synonymous with timely news and in-depth industry analysis.
Hard hitting, thorough coverage of vital industry concerns continues to this day to be the hallmark of Chain Drug Review. Armed with the assets of a seasoned and experienced editorial team, Chain Drug Review consistently produces a news publication that squarely confronts the challenges facing the chain drug industry today. Not only have retailers and suppliers come to rely on the news they read in Chain Drug Review, but on they also have come to rely on Chain Drug Review’s annual reports, chain profiles, merchandising features and statistical reports.
Many of the reports appearing in Chain Drug Review are held up as industry standards by both the retailing and investment communities. Retail Pharmacy, an exclusive section appearing monthly in Chain Drug Review, editorially focuses on the news and business of chain drug pharmacy.
Presently, Retail Pharmacy showcases six regular departments. They are News, Branded Drugs, Generic Drugs, Biotechnology, Education and Government.
*November 2008 BPA Publisher’s Statement